Sign in

NCT07714239Not yet recruiting

Pharmacist-Assisted Titration of Rx to Implement Optimal Medical Therapy for Heart Failure

Pharmacist-Assisted Titration of Rx to Implement Optimal Medical Therapy for Heart Failure (PATRIOT-HF) (QUE 25-018)

Source: ClinicalTrials.gov · Last updated 17 Sept 2026

Brief summary (registry, in English)

Many Veterans who are hospitalized with heart failure do not receive all the recommended heart medications at the right doses before they leave the hospital or in the weeks following discharge. This study tests whether a team of clinical pharmacists and cardiologists, working virtually, can improve heart failure medication prescribing for Veterans at VA medical centers. The pharmacist and cardiologist team reviews patient records and provides recommendations to the treating doctors and primary care providers caring for Veterans with heart failure. The goal is to increase use of guideline-recommended medications, which have been shown to improve survival, reduce hospitalizations, and improve quality of life.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
585 (estimated)
First submitted
15 Jul 2026
Start date
1 Nov 2026
Primary completion date
30 Sept 2030
Lead sponsor
VA Office of Research and Development
NCT number
NCT07714239

What you commit to

  • Study type: Interventional
  • Planned participants: 585
  • From 1 Nov 2026 to the primary completion date, 30 Sept 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving comfort care measures alone or enrolled in hospice

Other

  • Hemodynamic instability

Who the study is looking for

  • Admission to a VA medical center or VA-paid community hospital within the preceding 3 months with a primary diagnosis of heart failure
    • The primary study cohort will consist of those admitted to a VA medical center, while the secondary study cohort will consist of patients admitted to VA-paid community hospitals
  • Left ventricular ejection fraction ≤ 40%
  • Not on optimal guideline-directed heart failure medication classes or doses, as assessed in the electronic health record
  • Receiving care within one of the 6 participating VA medical centers

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rocky Mountain Regional VA Medical Center, Aurora, CO
Coordinator of this site? Confirm its status
AuroraUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.